-
灞呭畨璜� 绯犻吀鑾背鏉句钩鑶� 锟�37.80
-
灞呭畨璜� 鏉炶強鍦伴粌涓� 锟�23.80
-
灞呭畨璜� 楹濋澹鑶� 锟�23.80
-
灞呭畨璜� 闃胯啝 250g 锟�1089.00
鍛煎惛绯荤当(t菕ng)鐢ㄨ棩
瀵惰姖鏋楃恫(w菐ng)涓婅棩搴� > ?锛熸湸鐩�?/span> >鍛煎惛绯荤当(t菕ng)钘ュ搧鏄竴绋敤浜庡懠鍚哥郴绲�(t菕ng)鐤�?銆傘剤缂熻櫨绮戭弨鏍忚叆?锛屾敮姘g鐐�锛屾敮姘g鍝枠銆佹參鎬ф敮姘g鐐庡強鍏跺苟鐧�(f膩)鐧ョ瓑锛夌殑钘ュ搧銆傜敤浜庣珐瑙e懠鍚哥郴绲�(t菕ng)鐤剧梾鐨勫枠鎭�銆佸挸鍡借垏鍛煎惛琛扮绛夌櫏鐙€锛屾湁鏁堝湴闋�(y霉)闃插悎骞剁櫏鐨勭櫦(f膩)鐢�锛屽懠鍚哥郴绲�(t菕ng)鐢ㄨ棩涓昏鍖呮嫭绁涚棸钘�銆侀幃(zh猫n)鍜宠棩鍜屽钩鍠樿棩3绋�銆�
-
涔欑:閰稿凹閬�(d谩)灏煎竷杌熻啝鍥�
150mg*30绮�
鈼忕煶钘ラ泦鍦�(tu谩n)鎭╁繀鏅棩妤�(y猫)鏈夐檺鍏徃
浼婄怠(lu貌)閬�(d谩) 涔欑:閰稿凹閬�(d谩)灏煎竷杌熻啝鍥� 150mg*30绮�
缂鸿波 -
鍣绘墭婧撮姩濂ч仈(d谩)鐗圭緟鍚稿叆鍣撮湩鍔�
60鍣�
鈼廈oehringer Ingelheim Pharma GmbH & Co. KG
-
钀憺鑸�
绯犻吀姘熸浛鍗℃澗缍槶鐗圭緟鍚稿叆绮夐湩鍔�(鈪�)
30鍚�
鈼廏laxo Operations(UK)Ltd. (trading as Glaxo Wellcome Operations)
-
璜捐彲
鏍奸殕婧撮姩鍚稿叆绮夐湩鍔戠敤鑶犲泭
50渭g*30绮�(甯跺惛鍏ュ櫒)
鈼廚ovartis Pharma Stein AG
甯屾饯 鏍奸殕婧撮姩鍚稿叆绮夐湩鍔戠敤鑶犲泭 50渭g*30绮�(甯跺惛鍏ュ櫒)
-
淇″繀鍙兘淇�
甯冨湴濂堝痉绂忚帿鐗圭緟绮夊惛鍏ュ姂
160渭g:4.5渭g*120鍚�
鈼廇straZeneca AB
淇″繀鍙兘淇� 甯冨湴濂堝痉绂忚帿鐗圭緟绮夊惛... 160渭g:4.5渭g*120鍚�
-
鑸掑埄杩�
娌欑編鐗圭緟鏇垮崱鏉剧矇鍚稿叆鍔�
50渭g:500渭g*60娉�
鈼廏laxo Operations UK Limited
鑸掑埄杩� 娌欑編鐗圭緟鏇垮崱鏉剧矇鍚稿叆鍔� 50渭g:500渭g*60娉�
-
鏄傛饯
棣締閰歌寶閬�(d谩)鐗圭緟鍚稿叆绮夐湩鍔�
150渭g*30绮掞紙闄勪竴鍊�(g猫)钘ョ矇鍚稿叆鍣級
鈼廚ovartis Pharma Stein AG
鏄傛饯 姣旀柉娴锋▊ 棣締閰歌寶閬�(d谩)鐗圭緟鍚�... 150渭g*30绮掞紙闄勪竴鍊�(g猫)钘ョ矇鍚稿叆鍣級
-
闃挎柉鍒╁悍
甯冨湴濂堝痉绂忚帿鐗圭緟绮夊惛鍏ョ矇闇у姂(II)
320渭g:9渭g*60鍚�
鈼廇straZeneca AB
淇″繀鍙兘淇� 甯冨湴濂堝痉绂忚帿鐗圭緟绮夊惛... 320渭g:9渭g*60鍚�
-
闃挎柉鍒╁悍
鍚稿叆鐢ㄥ竷鍦板寰锋贩鎳告恫
2ml:0.5mg*30鏀�
鈼忔境澶у埄浜� AstraZeneca Pty Ltd
鏅背鍏嬩护鑸� 鍚稿叆鐢ㄥ竷鍦板寰锋贩鎳告恫 2ml:0.5mg*30鏀�
缂鸿波 -
鍟熺埦鏆�
鍊嶆隘绫虫澗绂忚帿鐗圭緟鍚稿叆姘i湩鍔�
100ug:6ug*120鎾�
鈼忔剰澶у埄 Chiesi Farmaceutici S.p.A.
鍟熺埦鏆� 鍊嶆隘绫虫澗绂忚帿鐗圭緟鍚稿叆姘i湩... 100ug:6ug*120鎾�
-
闃挎柉鍒╁悍
甯冨湴濂堝痉绂忚帿鐗圭緟绮夊惛鍏ョ矇闇у姂(II)
160渭g:4.5渭g*60鍚�
鈼廇straZeneca AB
淇″繀鍙兘淇� 甯冨湴濂堝痉绂忚帿鐗圭緟绮夊惛... 160渭g:4.5渭g*60鍚�
-
璜捐彲
鑼氶仈(d谩)鐗圭緟鏍奸殕婧撮姩鍚稿叆绮夐湩鍔戠敤鑶犲泭
110渭g/50渭g*30绮�(甯跺惛鍏ュ櫒)
鈼廚ovartis Farmaceutica SA
鏉版饯 鑼氶仈(d谩)鐗圭緟鏍奸殕婧撮姩鍚稿叆绮夐湩鍔�... 110渭g/50渭g*30绮�(甯跺惛鍏ュ櫒)
-
钁涜槶绱犲彶鍏�
鐑忕編婧撮姩缍槶鐗圭緟鍚稿叆绮夐湩鍔�
30鍚�
鈼廏laxo 0perations UK Ltd
-
姘熸浛缇庣董鍚稿叆绮夐湩鍔�
30鍚�
鈼廏laxo Operations UK Ltd (trading as Glaxo Wellcome Operations)
鍏ㄥ啀妯� 姘熸浛缇庣董鍚稿叆绮夐湩鍔� 30鍚�
-
闃挎柉鍒╁悍
甯冨湴鏍肩鍚稿叆姘i湩鍔�
120鎾�
鈼廇STRAZENECA DUNKERQUE PRODUCTION
鍊嶆搰鐟� 浠ゆ殺 甯冨湴鏍肩鍚稿叆姘i湩鍔� 120鎾�
-
鑸掑埄杩�
娌欑編鐗圭緟鏇垮崱鏉剧矇鍚稿叆鍔�
50渭g:250渭g*60娉�
鈼廏laxo Wellcome Production
鑸掑埄杩� 娌欑編鐗圭緟鏇垮崱鏉剧矇鍚稿叆鍔� 50渭g:250渭g*60娉�
-
闋嗙埦瀵�
瀛熼鍙哥壒閳夌墖
10mg*30鐗�
鈼廙erck Sharp & Dohme Ltd
闋嗙埦瀵� 瀛熼鍙哥壒閳夌墖 10mg*30鐗�
-
闃挎柉鍒╁悍
鏍奸殕婧撮姩绂忚帿鐗圭緟鍚稿叆姘i湩鍔�
7.2渭g:5.0渭g*120鎾�
鈼忚嫳鍦� Recipharm HC Limited
鐧炬矁骞� 浠ゆ殺 鏍奸殕婧撮姩绂忚帿鐗圭緟鍚�... 7.2渭g:5.0渭g*120鎾�
-
闃挎柉鍒╁悍
甯冨湴濂堝痉绂忚帿鐗圭緟绮夊惛鍏ョ矇闇у姂(I)
80渭g/4.5渭g*60鍚�
鈼廇straZeneca AB
淇″繀鍙兘淇� 甯冨湴濂堝痉绂忚帿鐗圭緟绮夊惛... 80渭g/4.5渭g*60鍚�
-
鎬濆姏鑿�
鍣绘墭婧撮姩绮夊惛鍏ュ姂
18ug*10绮�+1鍊�(g猫)钘ョ矇鍚稿叆鍣�
鈼廈oehringer Ingelheim Pharma GmbH & Co. KG
鎬濆姏鑿� 鍣绘墭婧撮姩绮夊惛鍏ュ姂 18ug*10绮�+1鍊�(g猫)钘ョ矇鍚稿叆鍣�
-
鑸掑埄杩�
娌欑編鐗圭緟鏇垮崱鏉剧矇鍚稿叆鍔�
50渭g:100渭g*60娉�
鈼廏laxo Operations UK Limited
鑸掑埄杩� 娌欑編鐗圭緟鏇垮崱鏉剧矇鍚稿叆鍔� 50渭g:100渭g*60娉�
-
鎬濆姏鑿�
鍣绘墭婧撮姩绮夊惛鍏ュ姂
18ug*10绮�
鈼忓痉鍦� Boehringer Ingelheim Pharma GmbH & Co. KG
鎬濆姏鑿� 鍣绘墭婧撮姩绮夊惛鍏ュ姂 18ug*10绮�
-
钁涜槶绱犲彶鍏�
涓欓吀姘熸浛鍗℃澗闇у寲鍚稿叆鐢ㄦ贩鎳告恫
2ml:0.5mg*10鏀�
鈼廏laxoSmithKline Australia Pty Ltd.
杓旇垝閰� 涓欓吀姘熸浛鍗℃澗闇у寲鍚稿叆鐢ㄦ贩... 2ml:0.5mg*10鏀�
-
杓旇垝閰�
涓欓吀姘熸浛鍗℃澗鍚稿叆姘i湩鍔�
50ug*120鍣�
鈼忔境澶у埄浜� GlaxoSmithKline Australia Pty Ltd.
杓旇垝閰� 涓欓吀姘熸浛鍗℃澗鍚稿叆姘i湩鍔� 50ug*120鍣�
-
闃挎柉鍒╁悍
纭吀鐗瑰竷浠栨灄闇у寲娑�
2ml:5mg*5鏀�*4琚�
鈼忕憺鍏窤straZeneca AB
鍗氬埄搴峰凹 纭吀鐗瑰竷浠栨灄闇у寲娑� 2ml:5mg*5鏀�*4琚�